Sweden· SE-20200403000032
Nimotop 0,2 mg/ml Infusionsvätska, lösning
A medicinal product containing nimodipine, registered in Sweden by Abboxia AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Nimodipine
- Manufacturer
- Abboxia AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- July 2, 2026
Packs & prices · 1
- se_varunummer20200403000032
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nimodipine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandNimodipine AltanAltan Pharmaceuticals, S.A.
- FinlandNimotopParanova Oy
- SpainNIMODIPINO ALTAN 0,2 MG/ML SOLUCION PARA PERFUSION EFGAltan Pharmaceuticals Sa
- CzechiaDILCERENZentiva, k.s., Praha
- BelgiumNimotop 10 mg/50 mlLaboratoire X.O
- NetherlandsNimotop 0,2 mg/ml, oplossing voor infusieLaboratoire X.O.
- NorwayNimotopLaboratoire X.O.
- SwitzerlandNimotop 10 mg/50 ml, InfusionslösungFuture Health Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Nimotop
- Belgium · Nimotop
- Bulgaria · Нимотоп S
- Cyprus · Nemotan
- Czechia · Dilceren, Nimotop S
- Germany · Nimodipin Carinopharm, Nimodipin Ethypharm
- Denmark · Nimotop
- Estonia · Nimotop
- Spain · Brainal, Nimodipino Altan
- Finland · Nimotop
- France · Nimodipine Altan, Nimotop
- United Kingdom (Northern Ireland) · Nimotop
- Greece · Befimat, Curban
- Croatia · Nimotop S
- Ireland · Nimotop
- Italy · Iskidrop, Nimobrain
- Luxembourg · Nimotop
- Latvia · Nimotop
- Netherlands · Nimotop
- Norway · Nimotop
- Poland · Nimotop S
- Portugal · Brainox, Modina
- Romania · Nimotop
- Slovenia · Nimodipin Bayer, Nimodipin Laboratoire X.O
- Slovakia · Dilceren Pro Infusione, Nemotan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e93c021a-69c7-4887-a93a-3f1d4f949ecb GET /v1/drugs/e93c021a-69c7-4887-a93a-3f1d4f949ecb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL"
],
"se_npl_id": "20200403000032",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20200403000032",
"product_doc_link": "https://docetp.mpa.se/LMF/Nimotop%200.2%20mg%20per%20ml%20solution%20for%20infusion%20BG%20PL_09001bee81c54a28.pdf"
}See everything about nimodipine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.